---
document_datetime: 2023-09-21 18:55:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/alimta-epar-all-authorised-presentations_en.pdf
document_name: alimta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6998773
conversion_datetime: 2025-12-19 02:58:03.831987
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration Immediate Packaging Pack size

| EU/1/04/290/001   | Alimta   | 500mg   | Powder for concentrate for solution for infusion   | Intravenous use   | vial (glass)   | 1 vial   |
|-------------------|----------|---------|----------------------------------------------------|-------------------|----------------|----------|
| EU/1/04/290/002   | Alimta   | 100mg   | Powder for concentrate for solution for infusion   | Intravenous use   | vial (glass)   | 1 vial   |